Professor of Medicine
Director of Division of Rheumatology
University of Toronto
Toronto General Research Institute
Dr. Bombardier is a widely published clinical researcher and rheumatologist. She is currently a Senior Scientist for the Toronto General Research Institute and is the Co-Lead for ECHO-Rheumatology. Former titles include: Director of Rheumatology for the University of Toronto and Co-Scientific Director at the Canadian Arthritis Network. She has held a Pfizer Research Chair in Rheumatology and a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care.
She is an international expert for quality improvement research, and has led the development of guidelines for the safe pharmacologic treatment of rheumatoid arthritis patients in Canada and abroad. Dr. Bombardier has published more than 358 scholarly articles is the recipient of numerous competitive awards and grants.
Dr. Bombardier has received many international and Canadian awards, including the ACR Distinguished Clinician Scholar Award (11/2017) and the prestigious American College of Rheumatology Master Designation Award (MACR) in 2013 for outstanding contributions in the field of rheumatology. In 2005, Dr. Bombardier founded the Ontario Best Practice Research Initiative (OBRI – www.obri.ca) to monitor the safety and efficacy of treatments for people with rheumatoid arthritis to improve treatment and quality of care for people in Ontario.
Her commitment to excellence in rheumatology is recognized, and as a Principal Investigator brings research expertise and visionary leadership to the OBRI team.
Professional interests include the improvement of clinical effectiveness, optimum use of technology and drugs, clinical economics, performance measurement/program evaluation, health research methods (clinical trials), knowledge transfer and workplace/rehabilitation, with a focus on musculoskeletal disorders.